Emil Kendziorra of Tomorrow Biostasis on extending the human lifespan

Ever since I was a child I was interested in the longevity and life extension field. In my mind, it should be an individual’s choice how long they would like to live. I studied medicine, went into (cancer-) research, and then entrepreneurship to do everything I can to make that happen. The organization I’m now running  I don’t plan to sell or leave at any point in time, they are mission-driven organizations for this long-term goal!

Tomorrow Biostasis is a biotech research company that offers what is called “medical cryopreservation”. Cryopreservation uses ultra-low temperature and specific cryoprotective agents to preserve organs or whole bodies to avoid degradation. Should one of our members/customers die, they signed up to be cryopreserved after death for the chance that the disease that led to their death will be curable and in the future resuscitation will be possible. It’s important to state that there is still a tremendous amount of research to be done to make this possible. So it’s just a chance for now. We’re also a biomedical research organization that does that very research.

“Longevity escape velocity” is the idea that at some point in the (potentially far) future, medical technology will have advanced enough that new treatments can cure diseases and improve health so efficiently that every year you live, you can add more than one year of additional life span. Once that is the case, people would be able to choose how long they want to live without diseases or old age limiting their life span. I think this is a very worthwhile goal, albeit I think it will take a very long-time to achieve it (biology is just extremely complex). That is why I decided to focus on cryopreservation.

Providing everybody with the chance to live as long as they want, at an affordable price. I’m personally motivated by that and I think everybody should have the opportunity to choose how long they would like to live. In the end, we’re working to give people a choice about how long they would like to live.

Most important from a research/science point of view: solving the replication crisis (i.e. little biomedical research can be replicated), new models to incentive and reward research, better science communication, and novel approaches to research publishing (e.g. DeSci, but quite difficult in detail). Otherwise, realizing the promises of personalized medicine, moving healthcare compensation to an outcome-based system, etc etc etc. Much to do 🙂

Anybody who does unique things and/or has a good answer to why they do what they do. Since we actually regularly host dinner parties, feel free to reach out if you want to join 🙂